Chronic migraine plus medication overuse headache: two entities or not?

Andrea Negro, Paolo Martelletti · The Journal of Headache and Pain · 2011

Summary

The Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program proved that patients with CM, even those with MOH, are the ones most likely to benefit from onabotulinumtoxinA treatment, and provided an injection paradigm that can be used as a guide for a correct administration of onabOTulinumToxinA.

Type: review
Published: 2011-09-22
Cited by: 105
References: 97
Access: Open access
DOI: https://doi.org/10.1007/s10194-011-0388-3
PubMed: https://pubmed.ncbi.nlm.nih.gov/21938457/
PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/3208042/
OpenAlex: https://openalex.org/W2013499403
Semantic Scholar: https://api.semanticscholar.org/CorpusID:6799969

Keywords

Medicine, Migraine, Chronic Migraine, Topiramate, Adverse effect

References

Family History for Chronic Headache and Drug Overuse as a Risk Factor for Headache Chronification何燕娟, 刘检, 史梅 — 2009
Anxiety disorders in headache patients in a specialised clinic: prevalence and symptoms in comparison to patients in a general neurological clinicSamuel E. D. Tampubolon — 2011
Botulinum toxin in migraine prophylaxisH. G�bel — 2004
Risk Factors for Headache ChronificationI Scher, Lynn A. Midgette, Richard B. Lipton — 2007
Short‐term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headachePaolo Rossi, J. Faroni, Giuseppe Nappi — 2011
Management of medication overuse headacheDrug and Therapeutics Bulletin — 2009
Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.R Hering, TJ Steiner — 1991
What predicts the change from episodic to chronic migraine?Marcelo E. Bigal, Richard B. Lipton — 2009
A Multi‐Center Double‐Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic MigraineRoger Cady, Curtis P. Schreiber, John A. H. Porter — 2011
From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countriesMarta Allena, Zaza Katsarava, Giuseppe Nappi — 2009
Topiramate in Migraine Prevention: Results of a Large Controlled TrialStephen D. Silberstein — 2004
Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective StudyZaza Katsarava, M. Muessig, Anna Dzagnidze — 2005
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraineSheena K. Aurora, Hans‐Christoph Diener, David W. Dodick — 2011
Licence for Botox in so-called chronic migraine.Jes Olesen, Peer Tfelt‐Hansen — 2010
Predictors of Response to Botulinum Toxin Type A (BoNTA) in Chronic Daily HeadacheNinan T. Mathew, Jayasree Kailasam, Lori Meadors — 2007
Overuse of acute migraine medications and migraine chronificationMarcelo E. Bigal, Richard B. Lipton — 2009
Drug-Induced Headache: Long-Term Follow-Up of Withdrawal Therapy and Persistence of Drug MisuseG. Fritsche, A Eberl, Zaza Katsarava — 2001
Putative mechanisms of the relationship between obesity and migraine progressionMarcelo E. Bigal, Richard B. Lipton — 2008
Topiramate in migraine progressionLuigi Ruiz, Delfina Ferrandi — 2009
EXCESSIVE ACUTE MIGRAINE MEDICATION USE AND MIGRAINE PROGRESSIONNitin K. Sethi — 2009

Cited by

Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in ChinaKlaus E Anerud — 2015
Psychosomatik der KopfschmerzenPeter Kropp, Thomas Dresler, Uwe Niederberger — 2014
Life-course-Betrachtung der häufigsten KopfschmerzformenStefanie Förderreuther — 2014
Update on Medication-Overuse Headache and Its TreatmentMaria Adele Giamberardino, Dimos D. Mitsikostas, Paolo Martelletti — 2015
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headacheElisa Bellei, Emanuela Monari, Stefania Bergamini — 2015
Effectiveness of intravenous Dexamethasone versus Propofol for pain relief in the migraine headache: A prospective double blind randomized clinical trialHassan Soleimanpour, Rouzbeh Rajaei Ghafouri, Aliakbar Taheraghdam — 2012
Chronic migraine classification: one more attempt of optimization and criteria revisionV. В. Osipova, Г. Р. Табеева, T. G. Voznesenskaya — 2012
Treatment of Perimenstrual Migraine with Triptans: an UpdateBarbara Casolla, Luana Lionetto, Serena Candela — 2012
Medication overuse headaches.Bernard M. Abrams — 2013
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxietyGuy Boudreau, Brian M. Grosberg, Peter J. McAllister — 2015
Medication overuse headache – An under-diagnosed problem in shunted idiopathic intracranial hypertension patientsRuth‐Mary deSouza, Ahmed K. Toma, Laurence Watkins — 2015
Medication Overuse HeadacheSigne Bruun Munksgaard, Rigmor Jensen — 2014
Chronic migraine classification: current knowledge and future perspectivesOn behalf of ANIRCEF (Associazione Neurologica Italiana Ricerca Cefalee), Gian Camillo Manzoni, V. Bonavita — 2011
Questioning on consistency of a Stagnation Scale in Medication Overuse Headache: one more added to a plea of emperor’s clothes?Marco Innamorati, Maurizio Pompili, Paolo Martelletti — 2015
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosisAn-Sofie OM Goessaert, Karel Everaert — 2012
Botox en la migraña crónicaFayyaz Ahmed — 2015
Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian populationGiovanna Gentile, Andrea Negro, Lidia D’Alonzo — 2015
Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuseFayyaz Ahmed, H Zafar, Alina Buture — 2015
Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trialPaolo Rossi, J. Faroni, Cristina Tassorelli — 2013
Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UKModar Khalil, H Zafar, V Quarshie — 2014

Chronic migraine plus medication overuse headache: two entities or not?

Summary

Keywords

References

Cited by

Related papers